These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 9776302

  • 1. Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.
    McNaught KS, Carrupt PA, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden CD.
    Biochem Pharmacol; 1998 Oct 15; 56(8):921-33. PubMed ID: 9776302
    [Abstract] [Full Text] [Related]

  • 2. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
    Storch A, Ott S, Hwang YI, Ortmann R, Hein A, Frenzel S, Matsubara K, Ohta S, Wolf HU, Schwarz J.
    Biochem Pharmacol; 2002 Mar 01; 63(5):909-20. PubMed ID: 11911843
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    McNaught KS, Thull U, Carrupt PA, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden CD.
    Biochem Pharmacol; 1996 Jul 12; 52(1):29-34. PubMed ID: 8678905
    [Abstract] [Full Text] [Related]

  • 4. Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration.
    McNaught KS, Thull U, Carrupt PA, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden CD.
    Biochem Pharmacol; 1996 Jun 14; 51(11):1503-11. PubMed ID: 8630091
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    McNaught KS, Thull U, Carrupt PA, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden CD.
    Biochem Pharmacol; 1995 Nov 27; 50(11):1903-11. PubMed ID: 8615871
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. N-methyltetrahydropyridines and pyridinium cations as toxins and comparison with naturally-occurring alkaloids.
    Herraiz T.
    Food Chem Toxicol; 2016 Nov 27; 97():23-39. PubMed ID: 27523294
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
    Naoi M, Dostert P, Yoshida M, Nagatsu T.
    Adv Neurol; 1993 Nov 27; 60():212-7. PubMed ID: 8420137
    [Abstract] [Full Text] [Related]

  • 14. Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives related to MPTP/MPP+.
    Booth RG, Castagnoli N, Rollema H.
    Neurosci Lett; 1989 May 22; 100(1-3):306-12. PubMed ID: 2788253
    [Abstract] [Full Text] [Related]

  • 15. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
    Naoi M, Maruyama W, Nagy GM.
    Neurotoxicology; 2004 Jan 22; 25(1-2):193-204. PubMed ID: 14697894
    [Abstract] [Full Text] [Related]

  • 16. [Contribution of MPTP to studies on the pathogenesis of Parkinson's disease].
    Mizuno Y.
    Rinsho Shinkeigaku; 1989 Dec 22; 29(12):1494-6. PubMed ID: 2698296
    [Abstract] [Full Text] [Related]

  • 17. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
    Ebadi M, Govitrapong P, Sharma S, Muralikrishnan D, Shavali S, Pellett L, Schafer R, Albano C, Eken J.
    Biol Signals Recept; 2001 Dec 22; 10(3-4):224-53. PubMed ID: 11351130
    [Abstract] [Full Text] [Related]

  • 18. Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances.
    Sayre LM, Wang FJ, Arora PK, Riachi NJ, Harik SI, Hoppel CL.
    J Neurochem; 1991 Dec 22; 57(6):2106-15. PubMed ID: 1940917
    [Abstract] [Full Text] [Related]

  • 19. Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease.
    Ebadi M, Sharma SK.
    Antioxid Redox Signal; 2003 Jun 22; 5(3):319-35. PubMed ID: 12880486
    [Abstract] [Full Text] [Related]

  • 20. Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin.
    Naoi M, Maruyama W, Niwa T, Nagatsu T.
    J Neural Transm Suppl; 1994 Jun 22; 41():197-205. PubMed ID: 7931227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.